notal vision
Better methods of detecting age-related macular degeneration.
notal vision has raised €72M across 2 funding rounds from 2 investors, most recently a Series D+ round in Jun 2021. Based in Tel Aviv, Israel; founded 2000; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€72M
€72,159,441
Funding rounds
2
Investors
2
distinct backers
Active since
2019-10
latest 2021-06
Funding by year
EUR raised per yearnotal vision — funding by year — interactive chart.
Data table
| notal vision — funding by year | |
|---|---|
| 2019 | €23M |
| 2021 | €49M |
Signals
High confidenceRaise-next likelihood11
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood4
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Old (26y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-06-09 | Series D+ | €49M | Ganot Capital,Soleus Capital | View deal → |
| 2019-10-01 | Series D+ | €23M | — | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData